Neal Shore, MD (Program Chair)
Director, CPI, Carolina Urologic Research Center
Myrtle Beach, South Carolina
Jason M. Hafron, MD
Chief Medical Officer and Partner
Michigan Institute of Urology, P.C
Urology William Beaumont School of Medicine
Director of Robotic Surgery
Beaumont Hospital Royal Oak
West Bloomfield, Michigan
This enduring activity will cover early detection and intervention in prostate cancer.
This activity is designed to meet the educational needs urologists, medical oncologists, and other HCPs responsible for treatment decisions for patients with prostate cancer, as well as primary care providers and other members of a multi-disciplinary care team involved in the management of Adverse Events (AE’s).
After completing the CME activity, learners should be better able to:
- Contrast the distinct mechanisms of action and clinical profiles of newer therapeutic regimens for the management of castration-sensitive prostate cancer (CSPC) in the early stages of disease and in the biochemical-recurrence setting
- Incorporate risk stratification approaches to inform clinical decision-making for the management of patients with CSPC
- Plan strategies for diagnosing and managing adverse events associated with newer therapeutic regimens for treating patients with CSPC
- Facilitate open communication and shared decision-making as part of patient-centered CSPC management
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose:This program would be beneficial for nurses involved in caring for patients with prostate cancer.
Credit: 1.0 ANCC Contact Hour
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
|Neal Shore, MD||Speakers Bureau||Astellas, AZ, Bayer, Clovis Oncology, Janssen, Merck, Pfizer Guardant Health, Foundation Medicine, Dendreon, Exact Imaging, Exact Sciences, and FerGene|
|Consultant||AbbVie, Amgen, Astellas, Astra Zeneca, Bayer, BMS, Boston Scientific, Clovis Oncology, and Cold Genesys|
|Jason M. Hafron, MD||Reports no relevant relationships with a commercial entity or manufacturer|
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff, Planners, and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sharine Griggs, Senior Program Manager for Med Learning Group, has nothing to disclose.
Diana Tommasi, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the pre- and post-test and evaluation form to Med Learning Group.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org.
RELEASE DATE: August 30, 2021
EXPIRATION DATE: August 30, 2022
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
Copyright © 2021 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.